| Primary |
| Rectal Cancer |
66.7% |
| Colon Cancer |
33.3% |
|
| Vomiting |
66.7% |
| Blood Urea Decreased |
33.3% |
|
| Secondary |
| Breast Cancer |
21.6% |
| Drug Use For Unknown Indication |
8.5% |
| Nasopharyngeal Cancer |
8.2% |
| Colorectal Cancer Metastatic |
6.3% |
| Non-small Cell Lung Cancer |
5.3% |
| Metastatic Gastric Cancer |
4.7% |
| Product Used For Unknown Indication |
4.7% |
| Colorectal Cancer |
3.8% |
| Hypertension |
3.8% |
| Oropharyngeal Cancer Stage Unspecified |
3.8% |
| Rhinitis Allergic |
3.8% |
| Gastric Cancer |
3.4% |
| Bladder Cancer |
3.1% |
| Hepatic Neoplasm Malignant |
3.1% |
| Constipation |
2.8% |
| Insomnia |
2.8% |
| Lung Neoplasm Malignant |
2.8% |
| Gastritis |
2.5% |
| Gastrooesophageal Reflux Disease |
2.5% |
| Rectal Cancer |
2.5% |
|
| Interstitial Lung Disease |
19.2% |
| Acute Myeloid Leukaemia |
9.6% |
| Hepatic Function Abnormal |
6.8% |
| Liver Disorder |
6.8% |
| Pancytopenia |
5.5% |
| Renal Impairment |
5.5% |
| White Blood Cell Count Decreased |
5.5% |
| Idiopathic Thrombocytopenic Purpura |
4.1% |
| Septic Shock |
4.1% |
| Stomatitis |
4.1% |
| Vomiting |
4.1% |
| Carcinoembryonic Antigen Increased |
2.7% |
| Diarrhoea |
2.7% |
| Disease Progression |
2.7% |
| Eosinophilic Pneumonia |
2.7% |
| Leukaemia |
2.7% |
| Myelodysplastic Syndrome |
2.7% |
| Nausea |
2.7% |
| Non-small Cell Lung Cancer |
2.7% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
2.7% |
|
| Concomitant |
| Breast Cancer |
19.5% |
| Metastatic Renal Cell Carcinoma |
10.1% |
| Hypertension |
8.5% |
| Drug Use For Unknown Indication |
7.5% |
| Metastases To Bone |
6.7% |
| Lip And/or Oral Cavity Cancer |
6.5% |
| Prostate Cancer Stage Iv |
5.9% |
| Hepatic Neoplasm Malignant |
3.4% |
| Diabetes Mellitus |
3.3% |
| Spinal Muscular Atrophy |
3.2% |
| Constipation |
3.1% |
| Cancer Pain |
3.0% |
| Benign Prostatic Hyperplasia |
2.7% |
| Insomnia |
2.5% |
| Prostate Cancer |
2.5% |
| Prophylaxis |
2.4% |
| Prostate Cancer Stage Iii |
2.4% |
| Colon Cancer |
2.3% |
| Gastritis |
2.3% |
| Back Pain |
2.2% |
|
| Osteonecrosis |
8.9% |
| Tooth Extraction |
8.9% |
| Interstitial Lung Disease |
8.2% |
| Pneumocystis Jiroveci Pneumonia |
7.5% |
| Rash |
7.5% |
| Wound Treatment |
6.2% |
| Toothache |
5.5% |
| Renal Impairment |
4.8% |
| Respiratory Failure |
4.8% |
| Somnolence |
4.8% |
| Prostate Cancer Stage Iv |
4.1% |
| Malaise |
3.4% |
| Malignant Neoplasm Progression |
3.4% |
| Neoplasm Malignant |
3.4% |
| Prostate Cancer |
3.4% |
| Pulmonary Infarction |
3.4% |
| White Blood Cell Count Decreased |
3.4% |
| Metastases To Liver |
2.7% |
| Pleural Effusion |
2.7% |
| Pollakiuria |
2.7% |
|
